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     Development of a photosensitizer that can work in both aerobic and anaerobic 
environments would increase the robustness of the cancer treatment known as 
photodynamic therapy.  The development of a photosensitizer was first attempted by 
synthesizing a tin (IV) meso-tetra (4-pyridyl) porphyrin dichloride-tetrachlorobis (Bipy)2 
ruthenium (II) complex.  The synthesize of the tin porphyrin was done by a method from 
literature and had a percent error of 31.58 and 37.31 when comparing the theoretical 
percentages of carbon (55.39) and nitrogen (12.92) meaning that photosensitizer was not 
synthesized.  
     The second type of chromophore that was studied was 1-nitropyrene do determine if it 
can act as a possible photosensitizer.  As a proof of concept, 1-nitropyrene can act as a 
photosensitizer by using visible light.   Upon visible light irradiation 1-nitropyrene can 
produce 1O2, ȮH, and possibly NO species under aerobic conditions and can produce ȮH 
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CHAPTER 1: SYNTHESIZE OF A TIN (IV) MESO-TETRA(4-PYRIDYL) 








     Recently, there has been a growing interest in the design and synthesis of new type of 
porphyrin based supramolecular complexes for a number of applications.  These include 
the capturing of solar energy to split water into oxygen and hydrogen gas to store solar 
energy in a fuel (1) and the production of reactive oxygen species for the photodynamic 
therapy medical application of treating cancer (2).  Several studies on visible light 
induced water oxidation have been done in the past where ruthenium metal complexes 
and other earth-abundant metal complexes have been used as a homogeneous catalyst (3).  
In almost all cases, a combination of a visible light photosensitizer, oxygen evolving 
complex and a sacrificial electron acceptor were used to produce oxygen gas (O2) from 
water.  Recently, Licheng Sun et al. reported a ruthenium based supramolecular complex, 
a covalently linked photosensitizer and catalyst for visible light–driven water oxidation 




water if there is no sacrificial electron acceptor molecule, such as sodium thiosulfate, in 
the solution.  A solution’s pH sometimes plays a very important role for the catalyst 
being in active form in the catalytic solution (5). Inspired by the structures of biological 
chlorophyll pigments and their light absorbing and electron transfer roles in the water 
oxidation process, a number of artificial photosynthetic systems were developed (6).  For 
the last couple of years, there has been growing interest in tin (IV) porphyrin based 
photocatalysts for splitting water into hydrogen and oxygen gas (7).  The major 
advantages of using tin(IV) porphyrins are as follows:  they are usually six coordinated 
with trans-diaxial ligands around a Sn4+ ion with a redox inert electron configuration 
([Kr]4d105S0) similar to the Mg2+ center of chlorophylls ([Ne]3S0);  they are known to 
have suitable redox potentials for water splitting;  they are easily accessible and stable 
against acid-induced demetallation (8,9).   Water oxidation by tin (IV) porphyrins has not 
been thoroughly explored. 
     Over the past decades, photodynamic therapy (PDT) has become an increasingly 
powerful method for the treatment for cancers, such as prostate, skin and lung cancers 
(10).  It is recognized as a promising new, effective, and noninvasive chemotherapeutic 
treatment.  Traditionally, photodynamic therapy involves the localization of 
photosensitizers in the target tissue.  Upon illumination with visible light, 
photosensitizers generate singlet oxygen (1O2) which is a critical intermediate involved in 
PDT, by reacting with dissolved oxygen in tissue.  Singlet oxygen causes damage to 




to DNA localized.  These treatments are better tolerated as they can treat diseased tissues 
effectively and non-invasively causing minimal nonspecific damage to other tissues (7) 
meaning that most of the damage is to cancer cells.  However, the current PDT method is 
facing some fundamental challenges, such as: (1) poor solubility of hydrophobic 
photosensitizers in biological media, (2) insufficient photosensitizer concentration at the 
target sites, (3) tumor hypoxia and (4) low selectivity of photosensitizers to the target 
sites.  Among these issues, tumor hypoxia, a state of low oxygen concentration in the 
tumor cells, is recognized as the greatest challenge that limits its clinical utility.  PDT-
photochemistry highly depends on the presence of oxygen (O2) for producing lethal 
singlet oxygen (1O2) (8).  A considerable amount of research has been carried out on 
methods for delivering cisplatin or other platinum metal-based chemotherapy drugs to the 
tumor sites.  However, despite its tremendous success, its use is limited because of the 
poor target selectivity and serious side-effects that occur during long-term traditional 
chemotherapy treatment.  Studies also indicate that hypoxic cells can exhibit considerable 
resistance to chemotherapy via several mechanisms one being inhibiting ROS 
development because of a lack of available oxygen (9).   
     Thus, development of a water-soluble photosensitizer, tin (IV) meso-tetra(4-pyridyl) 
porphyrin dichloride-tetrachlorobis(bipy)2 ruthenium (II), that will kill hypoxic cancer 
cells by splitting water and photoreacting with oxygen to form singlet oxygen is highly 
desirable.  Tin (IV) meso-tetra(4-pyridyl) porphyrin dichloride-tetrachlorobis(bipy)2 




     The proposed TinPorRuthCatalyst is an assembly of Sn (IV) meso-tetra(4-pyridyl) 
porphyrin dichloride (Sn-TPyP) and four [Ru(bipy)2Cl] substituents, shown in Figure 1.   
 
Figure 1:  Proposed structure of the TinPorRuthCatalyst. 
The meso-tetra(4-pyridyl) porphyrin (TPyP) and the ruthenium complexes consist of 
aromatic rings that absorb throughout the visible spectrum.  Specifically, the wavelength 
of one of the Q-bands of the porphyrin, 630 nm, is the light used for most PDT treatments 
(12).  Since it is well known that longer wavelengths (λ) of light penetrate deeper into 
biological tissue, the longer λ at 630 nm allows for better penetration than at the 
porphyrin’s Soret band, which is around 405 nm.  Since the ruthenium complex attaches 
to the outer nitrogens on TPyP, it increases the water solubility of the catalyst because of 




water insoluble photosensitizers are poorly absorbed into the bloodstream, causing a loss 
of its activity.  This loss of activity suggests that a stronger dose of the drug is needed to 
be effective, which in turn increases the toxicity of the photosensitizer (13).         
     It is not currently known if the complex in Figure 1 can be synthesized.  While 
the synthesis of the proposed catalyst has not been previously carried out, Araki et Al. 
(14) have synthesized a tetra-ruthenated porphyrin (TRuP), shown in Figure 2.  
 
Figure 2:  TPyP[Ru(bipy)2Cl4] synthesized by Araki (14). 
The porphyrin was synthesized by refluxing [Ru(bipy)2Cl2], with 5,10,15,20-Tetra(4-
pyridyl) porphyrin (TPyP) in glacial acetic acid with a molar ratio of 4:1.  The excess 
acetic acid was removed under vacuum and the solution was refluxed again with MeOH.  
Then the solution was precipitated by adding a saturated solution of LiCl/acetone.  The 
solid was washed with acetone and then dried under vacuum.  A CHN analysis, UV-Vis 




product was synthesized.  No crystal structure of TRuP nor a percent yield for the 
synthesis were reported.  The theoretical percentage of carbon, hydrogen, nitrogen in 
TRuP were calculated, which was 52.67, 4.05, and 12.28 %, respectively.  The 
percentage of C,H, and N obtained for TRuP corresponded well with theoretical 
percentage of C, H, and N.  The pecentage of C, H, and N obtained for TRuP were 51.96, 
4.08, and 12.32 %, respectively.  The UV-Vis spectra for TRuP exhibited absorption 
bands at 292, 356, 414, 470, 518, 584 and 642 nm.  The IR spectrum that was reported 
had peaks at 3060 w, 3008 w, 1600 s, 1560 w, 1551 w, 1470 sh, 1457 s,  1440 s, 1412 s, 
1398 sh, 1380 sh, 1345 w, 1304 s, 1260 m, 1235 w, 1231 sh, 1227 sh, 1225 m, 1207 w, 
1183 w, 1150 m, 1098 w, 1015 m, 975 w, 964 s, 879 m, 870 s, 845 w, 795 s, 760 s, 722 s, 
652 w, 560 w, 460 w, 420 w, 410 sh, and 390 w (m=medium, sh=shoulder, s=strong, 
w=weak).  All IR spectrum peaks are in cm-1.  Analysis of the IR spectrum revealed that 
a conjugated ring system was created.  The wide peaks at 3060 cm-1 and 3008 cm-1 were 
probably due to sp2 C-H symmetrical and asymmetrical stretches while the strong peak at 
1600 cm-1 and the shoulder peak at 1470 cm-1 were an indication of an aromatic C=C 
stretch.  Assigning the peaks of 1560 cm-1,1551 cm-1 and the peaks in the lower portion 
of the spectrum, from 1440 cm-1 through 390 cm-1, was difficult since many peaks fall 
within multiple ranges of many different types of modes and cannot be effectively 
interpreted.  The C-N stretch appeared within this region, 1350-1000 cm-1.  There was no 
indication of a sp or sp3 C-H stretch, C≡N stretch, C≡C stretch nor any stretches 




that there was no N-H stretch (3500-3300 cm-1) but it could be easily overshadowed by 
its central location in TPyP (15).  Another synthesis of a ruthenated-porphyrin was done 
by Mei (16).  In a study of DNA binding of porphyrin-ruthenium complexes, Mei et al 
used MPyTPP (5-Pyridine-10,15,20-triphenylporphyrin) and cis-Ru(pip)2Cl2 in a 1:1.5 
ratio refluxed with acetic acid under an argon atmosphere.  The solvent was removed and 
MeOH was added to the solid where it was once again refluxed for another 45 min.  The 
solid was precipitated in a similar method to that of Araki (14) by using a saturated 
solution of acetone/LiCl.  Mei and coworkers were able to obtain a percent yield of 56 % 
for the product [MPyTPP-Ru(pip)2Cl]
+. The product is shown in Figure 3. 
 
Figure 3: [MPyTPP-Ru(pip)2Cl]
+ structure synthesized by Mei (16). 
Araki was also able to synthesize a metalloporphyrin derivative of TPyP by reacting 
CoTPyP (Cobalt TPyP) with [Ru(bipy)2Cl2] in a 1:4 molar ratio (17).  The procedure was 
the same as in his earlier work, with the only difference being the starting material, 
CoTPyP, instead of TPyP.   




TinPorRuthCatalyst to be able to work in low oxygen environments.  The redox reactions 
and the overall reaction for water splitting are shown in equations {1}-{3}. (18) 
Oxidation half reaction 2𝐻2𝑂 ⇄  𝑂2 + 4𝐻
+ + 4𝑒− {1} 
Reduction half reaction 4𝐻+ + 4𝑒− ⇄ 2𝐻2 {2} 
Overall reaction 2𝐻2𝑂 ⇄  𝑂2 +  2𝐻2  {3} 
The splitting of water involves two half reactions: the oxidation reaction that forms O2 
and the reduction reaction that forms H2.  The main reaction that needs to be considered 
is the oxidation reaction because of the overpotential needed (1.23 V) compared with the 
reduction potential (0 V).  The overpotential can be supplied by a current, like in 
electrolysis, but this is not feasible within the human body.  Therefore, a catalyst would 
be needed to lower the energy necessary for this reaction.  Experiments with ruthenium 
complexes have been able to produce oxygen from water.  For example, in an article by 
Fei, (19) a triruthenium complex was synthesized and used as a photosensitizer with 
Na2S2O8 as the electron acceptor.  The redox potential of Ru
2+/Ru3+ was determined by 
cyclic voltammetry and was 0.74 V.   This is lower than the 1.23 V needed but only a 
ruthenium complex was used.  A porphyrin connected to multiple ruthenium complexes 
increases the catalytic activity of each individual molecule (20).  The redox potential 
indicates that it is thermodynamically possible to split water by a method that is similar to 
what Fei accomplished.  The O2 production was measured by an oxygen electrode, and 




this experiment that all three components, a photosensitizer, light source, and electron 
acceptor, were needed to oxidize water.  This was determined by conducting control 
experiments that measured O2 production as the photosensitizer was irradiated with light 
and without light.  It was found that when light irradiated the sample it produced O2 and 
without light, O2 production stopped.  In another experiment, Juris and coworkers 
determined that the reduction potential of [RuIII(bpy)3]
3+ was 1.21 V vs NHE (21).  In 
another study by Kim (22) the reduction potential of a tin porphyrin [SnIV(OH)2TPyP] 
attached with hydroxyl groups was measured in tetrahydrofuran (THF).  Its potential was 
determined to be 1.10 V.  The inclusion of both the tin porphyrin and ruthenium 
complexes should give enough energy to overcome the energy barrier for water splitting.  
Redox potentials of tin (IV) porphyrin complexes in aqueous media (pH = 7) reveal that 
the excited state of the tin (IV) porphyrins (Eox*S = -0.57 V, Eox*T = 0.19 V vs. NHE) can 
oxidize water into oxygen (9).  This process is thermodynamically favorable.           
      Recently, porphyrins and ruthenium complexes are shown to produce singlet oxygen 
from dioxygen upon with visible light irradiation (23).  Having a metal complexed at the 
center of a porphyrin has also been shown to increase the production of singlet oxygen.  
There are two types of pathways that are responsible for photooxidation reactions with 
DNA (Figure 4).  Type I involves a hydrogen abstraction from 2’deoxyguanosine, a DNA 
base, with the excited photosensitizer (photo*) forming 8-oxo-2’deoxyguanosine (24).  




photosensitizer, exciting the photosensitizer to a higher energy state (photo*) then the 









Figure 4: Type I & Type II photooxidation reactions with DNA. 
The transition from the triplet state of oxygen to the singlet state of oxygen is considered 
a “forbidden” transition as stated by the spin conservation principle.  This principle states 
that any transition that involves a change of multiplicity is forbidden.  A forbidden 
transition does not mean that the transition is impossible but means that the transition is 
improbable and not as likely to happen as a spin allowed transition.  Due to the ground 
state of molecular oxygen being paramagnetic, having unpaired electrons, the likelihood 
of these forbidden transitions increases.  This is because unpaired electrons can be 
perturbed more easily than spin paired electrons, diamagnetic.                  
     The viability of Type II over Type I for tetra-ruthenated porphyrins was shown by 
Araki (24).  Researchers calculated the ratio of Type II/Type I with calf-thymus DNA.  




value of 2.3 and the Zinc tetra-ruthenated porphyrin species (ZnTRP) was 5.6. See Figure 
5.  
 
Figure 5:  Structure of the superamolecule, ZnTRP. 
 Apparently, the Zn coordinated porphyrin caused an increase in singlet oxygen 
production.   The main issue with the singlet oxygen pathway is that it requires ground 
state oxygen to produce singlet oxygen.   
     Singlet oxygen can be determined by its emission band at around 1270 nm (25). This 
band is usually very weak and can be missed so the measurement of singlet oxygen will 
be determined by two other methods.  The first method, used by Chen, (26) involves the 





Figure 6:  Reaction of singlet oxygen with DHN. 
The production of juglone from DHN can be observed by UV-Visible spectroscopy by 
monitoring the maximum absorbance of both DHN (310 nm) and juglone (427 nm).  So, 
as DHN decreases, absorbance at 310 nm also decreases and as juglone increases the 
absorbance at 427 nm increases. The two changes in absorbance indicate that singlet 
oxygen was produced.  The second method uses N-benzoyl-DL-methionine (BZ-DL-
MET).  Zamadar and coworkers demonstrated that in the presence of singlet oxygen, BZ-
DL-MET oxidized and formed sulfoxide products (Figure 7) (27).   Compressed O2 was 
passed through a porous Vycor glass hollow core fiber optic coated with TPyP that was 
attached to a water solution containing BZ-DL-MET anion.  The proximal end of the 
fiber was irradiated with 532 nm light and the sulfoxide anion product formed at the 
distal end of the fiber with a percent yield of 5%.  The yield was improved to 11 % when 
the reaction was carried out in D2O.  An increase in yield was expected based on work by 
Lindig, because of the increased lifetime of singlet oxygen in D2O over H2O.  However, 




The less than expected increase was thought to be a surface effect involving adsorption or 
quenching of singlet oxygen by the silicon probe.   
Figure 7:  Reaction of BZ-DL-MET anion in presence of singlet oxygen. 
   
 
 




1.2.1. Materials and Instruments.  All reagent obtained were of the highest quality and 
used without further purification.  A Water Technologies deionization system was used to 
obtain deionized H2O.  Sn (IV) meso-tetra-(4-pyridyl) porphine dichloride (Sn Por) was 
purchased from Frontier Scientific, USA and Cis-dichlorobis(2,2’-bipyridine) Ru (II) 
(Ru(bipy)2 Cl2) was purchased from Sigma Aldrich, USA.  Methanol (MeOH) and 
acetone was obtained from VWR International, USA.  Acetic acid (12 M) was purchased 




Argon gas was obtained from Redball, USA.  CHN analysis was performed using a CN 
628 analyzer manufactured by Leco Corp. USA.       
1.2.2. Synthesis of TinPorRuthCat.  In a glove box, under argon atmosphere and at 
room temperature, approx. 0.156 g of Ru(bipy)2 Cl2 was placed into a 50 mL two-neck 
round bottom flask (RBF).  The RBF was then sealed with a septum and removed from 
the glove box.  A reflux apparatus (Figure 8) was set up where the RBF containing 
Ru(bipy)2 Cl2 was connected to a closed condenser and placed in a Thermowell wired to 
a Variac set to 100 volts.   
 
Figure 8: Setup for reflux apparatus. 
The reflux apparatus was kept under positive argon pressure.  Then 0.050 g of the Sn (IV) 
meso-tetra-(4-pyridyl) porphine dichloride and 5 mL of acetic acid were added to the 




hour and cooled to room temperature.  The acetic acid solution from the RBF was 
removed via distillation under reduced pressure (Figure 9). 
 
Figure 9: Distillation setup for removal of acetic acid. 
 
 After removal of acetic acid from the RBF, 5 mL of MeOH was added to the flask and 
the resulting solution was refluxed again for about 45 mins.  A saturated LiCl/acetone 
solution was prepared by mixing 1.0 g of LiCl into 55 mL of acetone for 20 mins.  The 
LiCl/acetone solution was added drop wise to the RBF which resulted in the formation of 
a black precipitate.  The precipitate was then collected by vacuum filtration and stored in 










1.3.1. Synthesis of TinPorRuthCat.  The characterization of the TinPorRuthCat was 
done using a CN 628 analyzer housed in the SFASU Soils Lab.  The results yielded a 
carbon % of 37.896 and a nitrogen % of 8.0995 (Table 1).  This is compared with the 
theoretical percent of carbon at 55.39 % and for nitrogen, 12.92 %.  Experimental values 
were different for carbon and nitrogen than expected with a percent error of 31.58 % and 
34.99%, respectively.  Since the % N and % C did not match the expected values for the 
TinPorRuthCat, it was evident that the catalyst was not synthesized.   
 Theoretical Actual % Error 
Theoretical 
Molecular Formula 







 % C (by weight) 55.39 37.896 31.58 
%N (by weight) 12.92 8.0995 37.31 
 
Table 1: Theoretical % of carbon and nitrogen compared with data obtained from a Leco 
CN 628 analyzer. 
 
Researchers have been able to synthesize a tin porphyrin and ruthenium complexes in 
glacial acetic acid (29) but sensitive characterization techniques, i.e. NMR, were not 
performed and purity was not determined.  Engelmann et al. (20) reported difficulty with 




ruthenium complexes after the solvent was changed from glacial acetic acid to an organic 
solvent mixture (CH2Cl2/ DMF) (10:1) with the addition of [Ru(bipy)2Cl(H2O)(NO3)] as 
a reagent.  From this procedure Engelmann et al. were able to get a yield of 90%.  It 
seemed that by refluxing with glacial acetic acid the pyridyl groups competed with the 
ruthenium complexes for solvent protons.  The competition for solvent protons resulted 
in compounds with different types of substituents which caused a loss in purity that 
affected the percent composition of the final product.  The UV-Vis spectrum of the 
synthesized product in ultrapure H2O are shown in Figure 10 with absorptions at 293, 
347, 418, 483, 563, and 606 nm. 
   
 




















The λ max is located at 418 nm and is consistent with unmetalated meso-tetra(4-pyridyl) 
porphyrins, along with absorptions of 563 and at 606 nm (30).  The absorption bands at 
293, 347 and 483 nm could be absorptions from ruthenium complexes (20).  From this 
data it can be concluded that the product synthesized is probably a tin porphyrin with 
various pyridyl and various amounts of ruthenium bipyridine complexes.  Further 
characterizations are needed to determine or speculate on the actual structure of the tin 







     The synthesis of the TinPorRuthCat was unsuccessful.  Theoretically the percentage 
of carbon and nitrogen, by weight, should be about 55.39 and 12.92 respectively.  The 
actual percentages were determined by CHN analysis to be 37.896 for carbon and 8.0995 
for nitrogen.  The method of synthesizing the TinPorRuthCat was the same method that 
Araki et al. developed and although a meso-tetraruthenated product was synthesized (14), 
many researchers were not able to synthesize a product with good purity.  Engelmann 
reported that using glacial acetic acid competed with pyridyl groups for solvent protons 
that caused the formations of other products with different substituents.  12 M acetic acid 




solvent protons, but this probably still a problem with the TinPorRuthCat and would 
cause the error in the percentages of carbon and nitrogen.  The TinPorRuthCat that was 
synthesized is probably a porphyrin that has unknown amounts of ruthenium complexes, 













     There are approximately 15.5 million people (31) living in the United States today 
suffering from cancer.  This number is expected to rise to 17 million by the end of this 
year.  Due to the widespread occurrence and the severity of cancer, scientists from all 
over the world are conducting a lot of research towards treating and detecting the various 
forms of cancer.  Many of the existing treatments for cancer are almost as bad as the 
disease itself because of the detrimental side effects (32).   In addition to side effects, 
another major challenge is that these treatments are not very target selective, meaning 
that they attack normal cells as well as cancer cells (33).  Photodynamic therapy (PDT) 
was developed in the 1990’s (34) to provide a cancer treatment that did not have the side 
effects and selectivity issues usually associated with other cancer treatments.  PDT uses a 
visible light source, usually a longer wavelength laser (35), to excite a photosensitive 
molecule, called a photosensitizer.  Photosensitizers are injected into the body where it is 




exciting the molecule to a higher energy state.  The excited photosensitizer molecules 
then release the excess energy into the surroundings.  Dissolved oxygen (O2) in the 
bodily fluid at the target plays an important role in PDT because the excess energy 
released from excited photosensitizer usually will excite ground state dissolved O2 to 
form reactive singlet oxygen (1O2).  Singlet oxygen is a short-lived and very fast, reactive 
oxygen species (ROS) that has been shown to cause cell death (36).  The current 
photosensitizers that are approved by the FDA are Photofrin®, Levulan® and Matvix® 
(37).  The main one that is used is Photofrin® with Levulan® and Matvix® used 
topically to treat skin cancers (37).  Although PDT has several advantages, there are some 
disadvantages that need to be improved upon to make PDT a viable clinical method for 
cancer treatment.  The major challenges of the current PDT treatment are dependent on 
the specific wavelength of light and tumor hypoxia.  The specific wavelength of light that 
is used to excite the photosensitizer molecules are important because longer wavelengths 
are able to penetrate body tissue better than shorter wavelengths (12).  This restricts the 
type of light that could be used; the light source needs enough energy to excite the 
molecule but needs to be of long enough wavelength to penetrate through the skin to 
reach cancerous tumors.  The major problem which limits PDT in clinical applications is 
tumor hypoxia, lack of adequate oxygen (O2) at the target site.  PDT can only be used in 
areas of the body that have access to oxygen which is a major problem in large cancer 
growths because cancer cells tend to create an oxygen poor environment (38). Thus, 




effective for hypoxic tumors.  There is a considerable amount of literature in which PDT 
is combined with other chemotherapeutic methods for targeting hypoxic tumors.  
Currently, there is no successful method that addresses all the major challenges of PDT.   
     We investigated, 1-nitropyrene (Figure 11), to determine if it can act as a 
photosensitizer and as a chemotherapeutic agent.  1-nitropyrene is a polyaromatic 
hydrocarbon (PAH) and is mostly found in the incomplete combustion of diesel exhaust. 
 
Figure 11: Structure of 1-nitropyrene. 
1-nitropyrene has been shown to be photo-transformed by visible light (39).  Zulma et al. 
reported that 1-nitropyrene’s photodegradation as well, by UV light in various organic 
solvents including nonpolar, protic and aprotic polar solvents (40).  Several 
photodegraded products have been identified (1-hydroxypyrene, methoxy pyrene, etc.) in 
polar organic solvents.  Several mechanisms have been proposed for explaining the 
different product formations (40).  For example, upon absorbing UV radiation, 1-
nitropyrene forms a nitrosopyrene intermediate, which subsequently converts into 




     As stated above, photodynamic therapy (PDT) requires three components to 
effectively kill cancer cells.  It needs a photosensitizer that will localize in cancer cells, a 
visible light source that can irradiate the photosensitizer, and an excess of O2 to create 
singlet oxygen (1O2) which is responsible for apoptosis of cancer cells (42).  If all three 
cannot be achieved, singlet oxygen will not be created, and PDT would be essentially 
ineffective as a cancer treatment method.   
     Singlet oxygen (1O2) is a reactive oxygen species that is higher in energy than O2. The 
energy difference occurs because both electrons in the singlet state are spin paired in the 
antibonding molecular orbitals while the ground state has the electrons non-spin paired, 
shown in Figure 12.  This spin-pairing makes singlet oxygen 95 kJ/mol higher in energy 
compared to ground state oxygen (43) and is responsible for the increase in reactivity of 
1O2.    
 






In quantum mechanics, the singlet state refers to the multiplicity of the oxygen molecule 
and is determined by the formula 2S + 1 where S refers to the total spin angular 
momentum.  The spin of electrons can only be ± ½; therefore, the total spin is equal to 
the total spin amount for all the electrons.  For singlet oxygen one electron is spin up (+ 
½) and one electron is spin down (- ½) so 2 *(0) + 1 = 1.  For ground state oxygen both 
electrons are spin up (+ ½) so S = 
2
2
, giving a multiplicity of 3 which is referred to as a 
triplet state.  
     Singlet oxygen can be determined by its emission band at around 1270 nm (43). Since 
the 1270 nm emission is usually very weak and can be missed, the measurement of 
singlet oxygen will be determined by using the fluorescent probe Singlet Oxygen Sensor 
Green (SOSG®).  The probe consists of a dyad of fluorescein and anthracene moieties 
that is non-fluorescent, Figure 13.   In the presence of singlet oxygen the non-fluorescent 
probe becomes fluorescent and can be detected around 525 nm.  SOSG is a very selective 
for singlet oxygen and negligibly reacts with other ROS (44).  
  




     Hydroxy radicals (ȮH) are another type of ROS that have an unpaired electron.  This 
makes ȮH very reactive (10-9s-1 in vivo) (45) and very destructive to any 
macromolecules.  Recent literature (46) indicated that the generation of ȮH in solution 
can be detected by using the fluorescence probes 3ʹ-(p-aminophenyl) fluorescein (APF) 
and 3ʹ-(p-hydroxyphenyl) fluorescein (HPF).  Both probes have a marked response for 
detecting ROS (Table 2) (47) with APF usually having a greater response than HPF.  
These probes have very small responses to light and large responses to ȮH and ONOO- 
making them useful in detection of ȮH.  However, they cannot be used to quantify the 
amount of ȮH being produced without minimizing the other possible ROS in solution.   
ROS ROS Generation Method APF HPF 
ȮH 100 μM of ferrous perchlorate (III) and 1 mM H2O2 1200 730 
ONOO- 3 μM (final) of ONOO- 560 120 
-OCl 3 μM (final) of -OCl 3600 6 
1O2 100 μM of 3-(1,4-dihydro-1,4-epidioxy-1-naphthyl) propionic 
acid 
9 5 
Ȯ2- 100 μM of KO2 6 8 
H2O2 100 μM of H2O2 <1 2 
NO 100 μM of 1-hydroxy-2-oxo-3(3aminopropyl)-3-methyl-1-
triazene 
<1 6 
ROȮ 100 μM of 2,2’-azobis(2-amidinopropane), dhihdrochloride 
(AAPH) 
2 17 
Auto-oxidation 2.5 hours exposure to fluorescent light source <1 <1 





Huang, et. al. summarized the recent development of reactive nitrogen donors and the 
anticancer drugs that are used in conjunction with nitrogen oxygen (NO) donors (48). 
Singh et al. showed that N-Nitrosothioproline (NTHP) conjugated magnetic nanoparticles 
can release a small amount of NO for killing cancerous cells without any toxic effect 
(49). Despite some success, there is still a great need for a new generation of NO donor-
based therapy with controlled release of appropriate levels of NO at the target site to kill 
the cancer cells.  The generation of NO can be detected by using the DAR-4M probe 
which is another type of fluorescent probe when excited 560 nm in the presence of NO 
species will fluoresce at 575 nm (50).     
     There is a need for a dual photosensitizer that can generate multiple reactive species. 
Fukuzumi, et al. reported that Metal Bacteriochlorins photosensitizers are dual 
photosensitizers.  These photosensitizers can produce singlet oxygen and superoxide 
reactive oxygen species (51).  However, these photosensitizers are ineffective in 
producing singlet oxygen and superoxide in absence of oxygen (O2) under visible light 
irradiation.  Thus, there is an increasing interest in finding photosensitizers which are 
capable of generating singlet oxygen and hydroxyl radicals in both aerobic and anaerobic 
conditions under visible light irradiation.  That is the reason for the research on 1-
nitropyrene to determine if it is capable of producing singlet oxygen, hydroxy radicals 




     Currently there is no literature on the photodegradation of 1-nitropyrene directly 
producing singlet oxygen, hydroxyl radicals or NO species.  However, there are indirect 
methods that indicate that the photodegradation of 1-nitropyrene and its derivatives go 
through a likely singlet oxygen and free radical process.  This is shown by Zang et al. 
(52) where it was reported that 1-aminopyrene is likely undergoing a singlet oxygen and 
free radical process by using histidine, a singlet oxygen quencher, upon light irradiation.  
In the light irradiation of 1-aminopyrene the photo-transformation rate decreased in the 
presence of histidine, implying that singlet oxygen was being produced.  This was further 
analyzed by adding both histidine and NaN3 a radical quencher, to the photo-
transformation of 1-aminopyrene, slowing the process 2.5 times the rate of just histidine, 
implying that singlet oxygen and other radicals were being produced.  Another article by 
Muck et. al (53) used three concentrations of H2O2 (5.0 x 10
-4, 5.0 x 10-3 and 5.0 x 10-2 
M) to study indirectly the photo-transformation of 1-nitropyrene upon visible light 
irradiation.  H2O2 is known to go through a direct photolysis (wavelength <340 nm) to 
produce hydroxy radicals.  These extra radicals should increase the rate of photo-
transformations if the reaction goes through a radical process.  The photo-transformation 
rate was shown to increase in the presence of H2O2 (1.0 x 10
-4 M) from 1.41 x 10-4 s-1 to 
2.8 x 10-4 s-1 mean while the reaction with the higher concentrations (5.0 x 10-3 and 5.0 x 
10-2 M) produced rates that were slightly faster with a rate of 1.7 x 10-4 s-1 for both 
concentrations.     




                 




2.2.1. Materials and Instruments.  All reagents obtained were HPLC quality and used 
without any purification.  A Water Technologies deionization system was used to obtain 
deionized H2O.  Most reagents were purchased from Sigma Aldrich, USA including; 1-
nitropyrene, 1-hydroxypyrene, dimethylformamide (DMF), dimethylsulfonate (DMSO), 
ethanol (EtOH), chloroform, dichloromethane (DCM), 1,2- dichloroethane (DCE), 35 % 
H2O2 and sodium azide (NaN3).  Hexane, acetone, and acetonitrile were purchased from 
VWR International, USA.  Methanol (MeOH) and the fluorescent probe; 
diaminohodamine-4M (DAR-4M) were purchased from EMD Millipore Corp, USA.  
Iron (III) chloride, Iron (II) chloride and cyclohexane were purchased from Flinn 
Scientific, USA.  The other fluorescent probes; singlet oxygen green sensor (SOSG), 3’-
(p-aminophenyl) fluorescein (APF), and 3’-(p-hydroxyphenyl) fluorescein (HPF), were 
obtained from Invitrogen, USA.  UV-Visible spectra were recorded from a double beam 
spectrophotometer model number UV-2550(PC) by the Shimadzu Corporation, Japan.  
Fluorescent spectra were recorded by a Perkin-Elmer, USA LS-55 at room temperature.  
Photo-transformation experiments were carried out with a Rayonet photochemical reactor 
model number RPR-100 manufactured by The Southern New England Ultraviolet 




model numbers; MDL-III-447-20mW-15067137 and MBL-III-473nm-20mW-15050686) 
and two blue lasers (532 and 556 model numbers; MGL-III-532-20mW-15077107 and 
MGL-FN-556-20mW-15070827) purchased from Changchun New Industries 
Optoelectronics Tech. Co, Ltd. China.   
2.2.2.  Photo-transformation of 1-Nitropyrene in Visible Light in 
Dimethylformamide (DMF) in Aerobic Conditions.  A 3 mL solution of 1-nitropyrene 
(1.0 x 10-4 M) in DMF was prepared at room temperature (RT) under normal atmospheric 
pressure.  The photo-transformation of 1-nitropyrene was carried out in a Rayonet 
photochemical reactor (185 nm - 575 nm) for approximately 30 mins.  The photo-
transformation of 1-nitropyrene was monitored by UV-Vis spectra obtained in 2 min 
intervals.  
2.2.3.  Photo-transformation of 1-Nitropyrene in Visible Light in 
Dimethylformamide (DMF) in Anaerobic Conditions.  A 3 mL solution of 1-
nitropyrene (1.0 x 10-4 M) in DMF was prepared at room temperature (RT) under normal 
atmospheric pressure.  The resulting solution was purged with argon gas for 20 mins to 
remove any traces of oxygen in solution.  The photo-transformation of 1-nitropyrene was 
carried out in a Rayonet photochemical reactor (185 nm - 575 nm) for approximately 30 
min.  The photo-transformation of 1-nitropyrene was monitored by UV-Vis spectra 




2.2.4.  The Effect of Various Solvents on the Rate of Photo-transformation of 1-
Nitropyrene.  A 3 mL solution of 1-nitropyrene (1.0 x 10-4 M) was prepared in various 
solvents that include nonpolar (hexane and cyclohexane), polar aprotic (acetone, DMF, 
acetonitrile, and DMSO), halogenated (chloroform, DCM, and DCE) and polar protic 
solvent (ethanol) at room temperature and normal atmospheric environment.  The 1-
nitropyrene solution was photo-transformed with a Rayonet photochemical reactor for 
about 20 mins.  UV-Vis absorption was recorded in intervals of 2 min.  A similar 
experimental procedure was followed for the photo-transformation under anaerobic 
conditions.  A 3 mL solution of 1-nitropyrene (1.0 x 10-4 M) was prepared in various 
solvents and then each solution was purged with argon for 20 mins in a sealed cuvette.  
The solution was then irradiated with a Rayonet photochemical reactor for 20 mins with 
the UV-Vis spectrum recorded every 2 mins.  The experiment was done in triplicate for 
aerobic/anaerobic to establish a reasonable first order photo-transformation rate of 1-
nitropyrene in each solvent.        
2.2.5. Photo-transformation of 1-Nitropyrene at Different Wavelengths of 
Excitation.  A 3 ml solution of 1-nitropyrene (1.0 x 10-4 M) was prepared in either DMF 
or EtOH.  The cuvette was then irradiated continuously with a laser of a specific 
wavelength (447, 473, 532 and 556 nm) for 20 mins.  The UV-Vis spectrum was 
recorded in 2 min intervals for 20 mins.  Photo-transformation of 1-nitropyrene in 
anaerobic conditions was monitored similarly.  The solution of 1-nitropyrene was purged 




anaerobic experiments were done in triplicate with the spectra used to calculate 
reasonable photo-transformation rates of 1-nitropyrene for each wavelength of light used.  
2.2.6.  Effect of H2O2 on the Photodegradation of 1-Nitropyrene.  A stock solution of 
H2O2 (3.6 x 10
-2 M) was prepared with ultrapure H2O by adding 31.3 μL of 35 % (w/w) 
H2O2 diluted with 10 mL of ultrapure H2O.  The H2O2 stock solution was then added at 
0.83 μL, 83.3 μL and 833 μL to make three experimental concentrations of H2O2, 1.0 x 
10-2, 1.0 x 10-3 and 1.0 x 10-5 M, respectively in a 3 mL solution of 1-nitropyrene (1.0 x 
10-4 M) in EtOH.  The solutions were photo-transformed with a Rayonet photochemical 
reactor for about 20 mins.  UV-Vis absorption was recorded in 2 min intervals.  For 
anaerobic conditions, solutions were purged with argon for 20 mins in a sealed cuvette 
before a visible spectrum was recorded.  The experiment was done in triplicate for both 
aerobic/anaerobic to establish a suitable rate for the photodegradation of 1-nitropyrene 
with different concentrations of H2O2 in EtOH.        
2.2.7.  Detection of Singlet Oxygen.  To measure singlet oxygen, the fluorescent probe 
SOSG by Invitrogen was used.  The SOSG solution was prepared by adding 33 μL of 
MeOH to a single vial of 100 μg of SOSG as by following the direction as stated in the 
product’s manual.  The experimental solution was prepared by taking 6 μL of SOSG 
solution and placing it in a 3 mL solution of 1-nitropyrene (1.0 x 10-4 M) in MeOH.  
Another solution was prepared in a similar manner but with 1-hydroxypyrene (1.0 x 10-4 




Solutions were then irradiated with a 447 nm laser.  The fluorometer was set to excite at a 
wavelength of 504 nm with the excitation slit width set at 8 nm and an emission slit width 
of 5 nm.  Fluorescent spectra were obtained in 5 min intervals for 30 mins.     
2.2.8.  Detection of Hydroxyl Radicals.  Hydroxyl radicals were measured by using two 
different fluorescent probes, APF and HPF by Invitrogen.  The probes were recieved in a 
5mM solution in DMF.  The experimental solution was prepared by taking 2 μL of HPF 
or APF solution and placing it in a 3 mL solution of 1-nitropyrene (1.0 x 10-4 M) in DMF.  
Another solution was prepared in a similar manner with 1-hydroxypyrene (1.0 x 10-4 M).  
All solutions were prepared at room temperature and normal atmospheric pressure.  
Solution were then irradiated with a 447 nm laser.  The fluorometer was set to excite at a 
wavelength of 490 nm with the excitation slit width set at 10 nm and an emission slit 
width of 7 nm.  Fluorescent spectra were obtained for 30 mins in 5 min intervals.      
2.2.9.  In Vitro Effects of 1-Nitropyrene and 1-Hydroxypyrene inn BL21 E. coli.  The 
toxicity of singlet oxygen generated from photosensitization reaction of 1-nitropyrene 
(1.0 x 10-4 M) was studied by comparing cell growth of BL21 E. coli. bacteria under light 
irradiation with a control under dark conditions.  E. coli cells in Luria Broth (LB) Lennox 
formulation were grown in an incubator set at 28 ℃ (to match the measured temperature 
of the Rayonet reaction) until the beginning of the E. coli exponential growth phase (A600 
≈ 0.2).  A 1.0 mL aliquot was centrifuged for 5 mins at 10,000 x g.  The supernatant was 




sample was centrifuged again for 5 mins at 10,000 x g.  We resuspended in 495 μL of 
sterile water and then added 5 μL of sterile water (control), DMF (control), 1-nitropyrene 
or 1-hydroxypyrene.  Two aliquots (495 μL sterile water + 5 μL of sample) were taken 
with one being placed in a photochemical reactor and the other aliquot in the dark, to 
prevent light irradiation, for 30 mins.  After 30 mins, 20 μL of the aliquots from both the 
photochemical reactor and in the dark was spread evenly onto a LB agar plate.  The 
samples were labeled as “light” for the aliquot that was in the reactor or as “dark” for the 
aliquot that was placed in the dark.  Both plates were inverted and placed in an incubator 
set at 28℃ for up to 48 hours.  Each plate was qualitatively analyzed by visual inspection 
of the relative number of E. coli colonies.           
   
 
2.3.  Results and Discussion 
 
2.3.1.  Photo-Transformation of 1-Nitropyrene in Visible Light in 
Dimethylformamide (DMF) in Aerobic Conditions.  Figure 14 showed the absorption 
of 1-nitropyrene (1.0 x 10-4 M) in DMF before and after the solution was irradiated with 
visible light.  The absorption spectrum of 1-nitropyrene has three major absorptions at 
292, 375, and 408 nm.  Upon illumination of the 1-nitropyrene solution, the absorbance at 
292, 375, and 408 nm began to decrease with new absorption peaks increasing at 281 nm 
and in the range of 324-355 nm.  The change in absorbance suggests that 1-nitropyrene 




Zulma et al (40) reported that 1-nitropyrene produced hydroxypyrenes, 
hydroxynitropyrenens, and/or pyrenedions upon UV light irradiation.  Further studies 
suggested that the major product in the photo-transformation of 1-nitropyrene is 1-
hydroxypyrene.  There are three isosbestic points located at 284, 323, and 388 nm, which 
have the absorptions overlap each other.  This is a good indicator that the reaction 
converts directly into the product without going through an intermediate.  These points 
represent where the reactant and product absorptions and molar absorptivity are the same 
but the ratio between reactants and products are changing  In this specific it case 1-
nitropyrene is directly being photo-transformed into 1-hydroxypyrene (54).  In order to 
characterize the photo-transformation product of 1-nitropyrene, the absorption spectra of 
commercially available 1-hydroxypyrene was recorded.  As depicted in Figure 15, the 
absorption peaks of 1-hydroxypyrene very closely overlaid with the absorption peaks of 
the photo-transformation product of 1-nitropyrene.  Therefore, it appears that 1-
hydroxypyrene is one of the major photo-transformed products under stated reaction 
conditions.  Further characterization of the product would need to be carried out to show 
1-hydroxypyrene is the product.  An experiment was carried out to determine the stability 
of 1-hydroxypyrene under visible light irradiation.  Figure 16 showed a very negligible 
change in absorption of 1-hydroxypyrene under visible light irradiation.  This data 
suggests that 1-hydroxypyrene is stable under stated reaction conditions.  Other photo-




characterization of other products is out of the scope of this study due to lack of proper 
instruments in the department.     
2.3.2.  Photo-Transformation of 1-Nitropyrene in Visible Light in 
Dimethylformamide (DMF) in Anaerobic Conditions.  To determine the necessity of 
oxygen for photo-transformation of 1-nitropyrene, an experiment was carried out in 
which the solution of 1-nitropyrene was purged with argon and then irradiated with 
visible light.  Figure 17 shows the changes of absorbance of 1-nitropyrene under visible 
light in anaerobic conditions.  Results were similar to those obtained in the photo-
transformation of 1-nitropyrene in aerobic conditions.  Upon visible light irradiation, 
under anaerobic conditions the solution of 1-nitropyrene most likely produced 1-
hydroxypyrene as a major product as evidenced by the gradual reduction of absorptions 
at 292, 375, and 408 nm and increases in absorptions at 281, in the range of 324-355 nm 
and at 388 nm, matching the same absorptions in 1-hydroxypyrene.  There were also 
three isosbestic points at 286, 315, and 370 nm similar to the 1-nitropyrene spectra under 
aerobic conditions.  These points represent 1-nitropyrene is likely forming 1-
hydroxypyrene but isosbestic points are a good indicator that there is one to one 
conversion of reactants to products (54).    
2.3.3.  The Effect of Various Solvents on the Rate of Photo-Transformation of 1-
Nitropyrene.  To examine the solvent effect on the photo-transformation of 1-




of organic solvents (protic and nonprotic solvents) under both aerobic and anaerobic 
conditions.  Figures 18-37 show the changes of absorption of 1-nitropyrene in organic 
solvents in aerobic and anaerobic conditions.  The loss of absorption of 1-nitropyrene 
(monitored at 388 nm) was observed to follow first order kinetics for most solvents.  The 
rate constants were calculated by linear regression fitting of the experimental data 
(calculated absorbance values as ln(A0/(A) vs t, where A0 is the absorbance at time 0, and 
A is the absorbance at time t).  Table 3 lists all the rate constants (kobs (s
-1)) of photo-
transformation of 1-nitropyrene studied in various solvents under aerobic and anaerobic 
conditions.  
  Aerobic Anaerobic 
Solvent 
Rate Constant,   
R2 
Rate Constant,   
R2 
kobs(s-1) kobs(s-1) 
DCM 8.667 x 10-5 ± 0.0005 0.9891 8.333 x 10-5 ± 0.0004 0.9998 
DCE 1.933 x 10-4 ± 0.0003 0.9997 1.317 x 10-4 ± 0.0005 0.9974 
chloroform NA NA 1.167 x 10-4 ± 0.0004 0.9984 
cyclohexane NA NA 3.167 x 10-5 ± 0.0002 0.9474 
hexane 2.000 x 10-5 ± 0.0005 0.9575 2.667 x 10-5 ± 0.0002 0.9826 
acetone 1.083 x 10-4 ± 0.0010 0.9963 1.167 x 10-4 ± 0.0006 0.9877 
DMF 4.833 x 10-5 ± 0.0004 0.9920 5.667 x 10-5 ± 0.0001 0.9614 
DMSO 4.167 x 10-5 ± 0.0003 0.9372 4.667 x 10-5 ± 0.0002 0.9897 
acetonitrile 4.500 x 10-5 ± 0.0002 0.9996 4.500 x 10-5 ± 0.0005 0.9957 
ethanol 7.333 x 10-5 ± 0.0001 0.9977 6.833 x 10-5 ± 0.0001 0.9907 
Table 3: Solvent effects of photo-transformation of 1-nitropyrene at 388 nm at RT and 
atmospheric pressure. 
 As shown in Table 3, the rate of photo-transformation of 1-nitropyrene had a maximum 




and anaerobic conditions, respectively. The aprotic solvent acetone had the second 
highest rates of 1.083 x 10-4 s-1 and 1.167 x 10-4 s-1.  The other aprotic solvents, DMF, 
acetonitrile, and DMSO, had rates of approximately 4.722 x 10-5 s-1.  The protic solvent, 
ethanol had rates of 7.333 x 10-5 s-1 and 6.833 x 10-5 s-1 in aerobic and anaerobic 
conditions.  Interestingly, cyclohexane and chloroform does not follow first order kinetics 
under aerobic conditions (Figure 24 & 22) but first order kinetics were observed under 
anaerobic conditions (Figure 25 & 23).           
2.3.4. Photo-Transformation of 1-Nitropyrene in DMF and EtOH at Different 
Wavelengths of Excitation.  In order to examine the light effect on the photo-
transformation of 1-nitropyrene, a solution of 1-nitropyrene in DMF was irradiated at 
various wavelengths (Figures 38-45).  Table 4 shows the rate of photo-transformation of 







  Rate Constant, kobs(s-1)  R2 Rate Constant, kobs(s-1)  R2 
447 3.500 x 10-5 ± 0.0004 0.9930 3.000 x 10-5 ± 0.0003 0.9701 
473 5.000 x 10-6 ± 0.0001 0.9040 3.333 x 10-6 ± 0.0018 0.9258 
532 3.333 x 10-6 ± 0.0001 0.8417 1.667 x 10-6 ± 0.0001 0.5662 
556 3.333 x 10-6 ± 0.0002 0.9049 3.333 x 10-6 ± 0.0002 0.9391 
Table 4: Photo-transformation rates of 1-nitropyrene at 388 nm with different excitation 





The fastest rate observed was for 447 nm (3.500 x 10-5 s-1).  This was seen with an 
ethanol solution of 1-nitropyrene as well (Table 5 and Figures 46-53) with 447 nm having 
the highest rate (2.167 x 10-5 s-1).  For the higher wavelengths, 473, 532, and 556, the rate 






  Rate Constant, kobs(s-1)  R2 Rate Constant, kobs(s-1)  R2 
447 2.167 x 10-5 ± 0.0001 0.9975 2.667 x 10-5 ± 0.0001 0.9931 
473 6.667 x 10-6 ± 0.0002 0.8949 3.333 x 10-6 ± 0.00 0.7881 
532 3.333 x 10-6 ± 0.0001 0.9404 5.000 x 10-6 ± 0.0002 0.8615 
556 1.667 x 10-6 ± 0.0001 0.9200 5.000 x 10-6 ± 0.0001 0.8749 
Table 5: Photo-transformation rates of 1-nitropyrene at 388 nm with different excitation 
wavelengths in ethanol. 
For example, the rate of photo-transformation of 1-nitropyrene in DMF at 556 nm was 
measured to be 3.333 x 10-6 s-1.  This is probably due to the fact that 1-nitropyrene 
absorbs strongly at 294, 381 and 407 nm and after 470 nm the absorption of 1-
nitropyrene practically drops to zero.  This was done to compare a protic and aprotic 
solvent as a representation of all solvents with DMF and EtOH being chosen because 
they both had high rates and followed first order kinetics.         
2.3.5. Effect of H2O2 on the Photo-Transformation of 1-Nitropyrene in Ethanol.  In 
order to examine the photo-transformation properties of 1-nitropyrene in a hydrogen 
peroxide rich environment, a solution of 1-nitropyrene was irradiated at various 
concentrations under aerobic and anaerobic conditions.  H2O2 undergoes a photolysis to 




nitropyrene upon light irradiation. Three different concentrations of H2O2 (1.0 x 10
-2, 1.0 
x 10-3 and 1.0 x 10-5 M) in EtOH were tested (Figures 54-59). The rates of photo-
transformation of 1-nitropyrene in the presence of hydrogen peroxide are summarized in 




Rate Constant, kobs(s-1)  R2 Rate Constant, kobs(s-1) R2 
1.0 x 10-2  4.333 x 10-5 ± 0.0003 0.9940 4.500 x 10-5 ± 0.0001 0.996 
1.0 x 10-3 6.667 x 10-5 ± 0.0005 0.9944 5.667 x 10-5 ± 0.0001 0.995 
1.0 x 10-5 1.067 x 10-4 ± 0.0024 0.9960 5.167 x 10-5 ± 0.0014 0.997 
Table 6: Effects of three different concentrations of hydrogen peroxide on photo-
transformation of 1-nitropyrene at 388 nm in EtOH. 
 
At the highest H2O2 concentration (1.0 x 10
-2 M), the rate of photo-transformation of 1-
nitropyrene was slowed to 4.333 x 10-5 s-1 under aerobic and 4.500 x 10-5 s-1 under 
anerobic conditions.  This was compared to the rate of 1-nitropyrene in ethanol, 7.333 x 
10-5 s-1 under aerobic and 6.833 x 10-5 s-1 under anaerobic conditions (Table 3).  
Interestingly, an increased rate of photo-transformation of 1-nitropyrene was observed at 
the lower hydrogen peroxide concentration (1.0 x 10-5 M) with an aerobic rate constant of 
1.067 x 10-4 s-1 and a rate constant of 5.167 x 10-5 s-1 under anaerobic conditions.  The 
intermediate H2O2 concentration (1.0 x 10
-3 M) rate was in between 1.0 x 10-5 and 1.0 x 
10-2 M with an aerobic rate of 6.667 x 10-5 s-1 and an anaerobic rate of 5.667 x 10-5 s-1.  




(5.0 x 10-4 M) increased the rate meanwhile the higher concentrations (5.0 x 10-3 and 5.0 
x 10-2 M) where about the same rate as without H2O2.  Hydrogen peroxide, after creating 
hydroxy radicals, can further react with itself to form a superoxide which is less reactive 
than hydroxy radicals and thereby not changing the rate or even inhibiting the reaction 
(55).               
2.3.6. Detection of Singlet Oxygen.  The generation of 1O2 was detected by using singlet 
oxygen sensor green (SOSG).  Figure 60 shows that the fluorescence intensity of SOSG 
gradually increased with increasing amount of irradiation time, indicating 1O2 generation 
in the methanol solution of 1-nitropyrene.  The fluorescence spectra of SOSG was 
recorded immediately after irradiation.  When the 1-nitropyrene solution was irradiated 
with a 447 nm laser, the fluorescence intensity at 525 nm increased, indicating generation 
of singlet oxygen in solution.  Additional blank experiments revealed that the SOSG’s 
fluorescence intensity at 525 nm did not increase in the absence of light.  The 
fluorescence data gives a strong indication that the solution of 1-nitropyrene generates 
singlet oxygen (1O2) under visible light irradiation.  Figure 61 shows the fluorescent 
spectra of 1-nitropyrene in MeOH excited at 407 nm.  The fluorescent spectrum has a λ 
max around 496 with decreasing intensities until about 600 nm.  This means 1-
nitropyrene does have some emission with SOSG (525 nm) emission wavelength.  This 
could be further tested by conducting another experiment of monitoring the fluorescence 
of 1-nitropyrene after irradiating it with light to see if the intensity of 1-nitropyrene 




detect the generation of 1O2 by 1-hydroxypyrene (Figure 62).  The fluorescence intensity 
of SOSG gradually increased with increasing irradiation time, indicating the generation 
of 1O2 in the methanol solution of 1-hydroxypyrene.  An increase in the fluorescence 
intensity of SOSG at 520 nm was observed, indicating that 1-hydroxypyrene is capable of 
generating singlet oxygen in solution under visible light irradiation.  Figure 63 shows the 
fluorescent spectrum of 1-hydroxypyrene excited at 387 nm.  It clearly shows that 1-
hydroxypyrene does not emit light in the range of 500 – 800 nm so the emission at 525 is 
solely due to SOSG reacting with singlet oxygen generated by irradiating 1-
hydroxypyrene with visible light.   
2.3.7.  Detection of Hydroxyl Radicals.  To detect hydroxyl radicals, the fluorescence 
probes 3’-p-(aminophenyl) fluorescein (APF) and 3’-p-(hydroxyphenyl) fluorescein 
(HPF) were used.  Both of the probes become fluorescent when they are in contact with 
hydroxyl radicals.  Figure 64 shows that the fluorescence intensity of APF gradually 
increased with increasing amount of irradiation time of a solution of 1-nitropyrene in 
DMF.  The fluorescence intensity at 539 nm gradually increased with increasing amount 
of irradiation time under aerobic conditions.  No evidence of increasing fluorescence 
intensity of APF at 539 nm was observed in the dark.  This data indicates that the solution 
of 1-nitropyrene generates hydroxyl radicals under visible light irradiation in aerobic 
conditions.  Similar experiments were carried out to determine if the solution of 1-
nitropyrene produces hydroxyl radicals in situ in anaerobic conditions under visible light 




nitropyrene solution when irradiated under anaerobic conditions.  The fluorescence 
intensity of APF shifted to 560 nm and gradually increased in intensity with the amount 
of irradiation time.  A control reaction showed that the fluorescence intensity of APF 
significantly decreased when the solution of 1-nitropyrene and APF was irradiated in the 
presence of 1% DMSO (Figure 66).  DMSO is usually used to quench hydroxyl radicals 
in the solution.  A similar reaction was carried out by using sodium azide as a hydroxyl 
radical quencher.  As seen in other literature (17), a significant increase in fluorescence 
intensity of APF at 530 nm was observed upon visible light irradiation of the solution of 
1-nitropyrene, APF, and 1 mM NaN3 (Figure 67).  This data clearly indicates that the 
portion of the fluorescence of APF quenched by DMSO represents the contribution of 
hydroxyl radicals.  In order to determine the generation of hydroxyl radicals produced by 
1-hydroxypyrene, a similar APF experiment was conducted.  Figure 68 and Figure 69 
show the change of fluorescence intensity of APF when the solutions of 1-hydroxypyrene 
and APF were irradiated with visible light in aerobic and anaerobic conditions, 
respectively.  As seen for 1-nitropyrene, a gradual increase in fluorescence intensity of 
APF as observed in aerobic and anaerobic solutions.  This data suggests that the 1-
hydroxypyrene solution generates hydroxyl radicals in situ in aerobic and anaerobic 
solution.  Additional control experiments were conducted to confirm the hydroxyl 
radical’s generation by using 1% DMSO solution as a hydroxyl radical’s quencher.  




solution in the presence of 1% DMSO, similar to the observation with 1-nitropyrene.  The 
fluorescence intensity of APF showed an increase in the presence of NaN3 (Figure 71).   
     All experiments were repeated using another type of hydroxyl radical quencher, 3’-p-
(hydroxyphenyl) fluorescein (HPF), to detect the generation of hydroxyl radicals (Figures 
72-79).  Although both probes, APF and HPF, react with the same ROS their reactivity is 
different (Table 2) with APF having the strongest reactivity with hydroxy radicals but 
reacts stronger with other ROS than HPF.  However, HPF has less reactivity but reacts 
the strongest with hydroxy radicals.  1-nitropyrene produced similar changes in 
fluorescence intensity with HPF with increasing intensity at 539 nm under aerobic 
(Figure 72) and at 560 nm under anaerobic conditions (Figure 73).  There is an increase 
in fluorescence intensity of HPF with 1% DMSO and sodium azide in Figures 74 & 75.  
1-hydroxypyrene with HPF exhibited similar trends in aerobic an anaerobic condition 
(Figures 76-79).  These results collectively indicate that hydroxy radicals are produced in 
the photoinitiated reaction of 1-nitropyrene.          
2.3.8.  In Vitro Effects of 1-Nitropyrene and 1-Hydroxypyrene in BL21 E. coli.  To 
determine the antibacterial properties of 1-nitropyrene and 1-hydroxypyrene, solutions of 
1-nitropyrene and 1-hydroxypyrene were tested for their effects on the growth of E. coli 
bacteria as a model organism (Figure 80).  Figures 80-1 and 80-1a, show E. coli with just 
water, under dark and light conditions.  There is no inhibition of E. coli with sterile water 




solvent, DMF.  Similar results were obtained with no inhibition of E. coli. with DMF 
under dark or light conditions.  A significant inhibition of the growth of E. coli bacteria 
was observed when the 1-nitropyrene solution, in DMF, was illuminated with visible 
light (Figure 80- F). Under dark conditions (Figure 80-E) 1-nitropyrene had negligible 
inhibition of E. coli bacteria, indicating that 1-nitropyrene is non-toxic to E. coli under 
dark conditions.  Similarly, the treatment of E. coli bacteria with 1-hydroxypyrene 
showed almost 100% inhibition of growth under visible light irradiation (Figure 80-H). 
Interestingly, a significant inhibition of the growth was also observed with 1-
hydroxypyrene under dark conditions (Figure 80-G).  This data suggests that 1-
nitropyrene as well as 1-hydroxypyrene are potential antibacterial agents and can inhibit 
the growth of bacteria, particularly E. coli.  Furthermore, this data leads us to conclude 






     The product that is formed from the photo-transformation of 1-nitropyrene is likely 1-
hydroxypyrene.  (Figure 15) The overlay of 1-hydroxypyrene with 1-nitropyrene UV-Vis 
spectrums after irradiation with visible light, clearly shows an absorption decrease for 1-
nitropyrene (294, 378, 409 nm) and an increase in the absorptions associated with 1-




distinct isosbestic points which indicates that there is one major product.  The SOSG 
fluorescent probe was used to determine if singlet oxygen was produced from irradiating 
1-nitropyrene with visible light.  The specific fluorescent intensity of SOSG with 1-
nitropyrene increased with irradiation time indicating that singlet oxygen was produced.  
APF and HPF was used to determine if hydroxy radicals were produced with irradiation 
of 1-nitropyrene.  Like SOSG, fluorescence intensity of APF and HPF with 1-nitropyrene 
increased with irradiation time, an indicator that hydroxy radicals were produced, 
although there could be other ROS interacting with APF or HPF.  A study of the effect of 
1-nitropyrene on the inhibition of E. coli bacteria growth was done.  It was determined 
that 1-nitropyrene did not inhibit growth but only if irradiated with visible light did 1-
nitropyrene inhibited bacterial growth.   
     This proof of concept project provides preliminary data which indicates the photo-
transformation of 1-nitropyrene produces 1-hydroxypyrene, 1O2, as well as OH radicals 
in both aerobic and anaerobic conditions.  In additions, this preliminary data provides a 









Figure 14: Photo-transformation of 1-nitropyrene (1.0 x 10-4 M) in DMF with visible 
light for 55 min.  Blue (0 min) 
 
 
Figure 15: Overlay of absorption spectra of 1-nitropyrene (1.0 x 10-4 M) after 28 minutes 








































Figure 17: Photo-transformation of 1-nitropyrene (1.0 x 10-4 M) under anaerobic 




































Figure 18: Rate constant (kobs (min
-1) for 1-nitropyrene in DCM at 388 nm in aerobic 
conditions.  Monitored for 20 min with irradiation with visible light. 
 
 
Figure 19: Rate constant (kobs (min
-1) for 1-nitropyrene in DCM at 388 nm in anaerobic 
conditions.  Monitored for 20 min with irradiation with visible light 
 




































Figure 20: Rate constant (kobs (min
-1) for 1-nitropyrene in DCE at 388 nm in aerobic 
conditions.  Monitored for 20 min with irradiation with visible light 
 
 
Figure 21:  Rate constant (kobs (min
-1) for 1-nitropyrene in DCE at 388 nm in anaerobic 
conditions.  Monitored for 20 min with irradiation with visible light 
 

































Figure 22: Rate constant (kobs (min
-1) for 1-nitropyrene in CHCl3 at 388 nm in aerobic 




Figure 23: Rate constant (kobs (min
-1) for 1-nitropyrene in CHCl3 at 388 nm in anaerobic 
conditions.  Monitored for 20 min with irradiation with visible light 
 







































Figure 24: Rate constant (kobs (min
-1) for 1-nitropyrene in cyclohexane at 388 nm in 
aerobic conditions.  Monitored for 20 min with irradiation with visible light.  Did not 
follow first order kinetics. 
 
 
Figure 25: Rate constant (kobs (min
-1) for 1-nitropyrene in cyclohexane at 388 nm in 
anaerobic conditions.  Monitored for 20 min with irradiation with visible light 
 








































Figure 26: Rate constant (kobs (min
-1) for 1-nitropyrene in hexane at 388 nm in aerobic 
conditions.  Monitored for 20 min with irradiation with visible light 
 
 
Figure 27: Rate constant (kobs (min
-1) for 1-nitropyrene in hexane at 388 nm in anaerobic 
conditions.  Monitored for 20 min with irradiation with visible light 
 






































Figure 28: Rate constant (kobs (min
-1) for 1-nitropyrene in acetone at 388 nm in aerobic 




Figure 29: Rate constant (kobs (min
-1) for 1-nitropyrene in acetone at 388 nm in anaerobic 
conditions.  Monitored for 20 min with irradiation with visible light 
 







































Figure 30: Rate constant (kobs (min
-1) for 1-nitropyrene in DMF at 388 nm in aerobic 
conditions.  Monitored for 20 min with irradiation with visible light 
 
 
Figure 31: Rate constant (kobs (min
-1) for 1-nitropyrene in DMF at 388 nm in anaerobic 
conditions.  Monitored for 20 min with irradiation with visible light 
 








































Figure 32: Rate constant (kobs (min
-1) for 1-nitropyrene in DMSO at 388 nm in aerobic 




Figure 33: Rate constant (kobs (min
-1) for 1-nitropyrene in DMSO at 388 nm in anaerobic 
conditions.  Monitored for 20 min with irradiation with visible light 
 





































Figure 34: Rate constant (kobs (min
-1) for 1-nitropyrene in acetonitrile at 388 nm in 
aerobic conditions.  Monitored for 20 min with irradiation with visible light 
 
 
Figure 35: Rate constant (kobs (min
-1) for 1-nitropyrene in acetonitrile at 388 nm in 
anaerobic conditions.  Monitored for 20 min with irradiation with visible light 
 




































Figure 36: Rate constant (kobs (min
-1) for 1-nitropyrene in ethanol at 388 nm in aerobic 




Figure 37: Rate constant (kobs (min
-1) for 1-nitropyrene in ethanol at 388 nm in anaerobic 
conditions.  Monitored for 20 min with irradiation with visible light 
 


































Figure 38: Rate constant (kobs (min
-1) for 1-nitropyrene in DMF at 388 nm in aerobic 
conditions.  Monitored for 20 min with 447 nm light irradiation. 
 
 
Figure 39: Rate constant (kobs (min
-1) for 1-nitropyrene in DMF at 388 nm in anaerobic 
conditions.  Monitored for 20 min with 447 nm light irradiation 
 




































Figure 40: Rate constant (kobs (min
-1) for 1-nitropyrene in DMF at 388 nm in aerobic 
conditions.  Monitored for 20 min with 473 nm light irradiation 
 
 
Figure 41: Rate constant (kobs (min
-1) for 1-nitropyrene in DMF at 388 nm in anaerobic 
conditions.  Monitored for 20 min with 473 nm light irradiation 
 










































Figure 42: Rate constant (kobs (min
-1) for 1-nitropyrene in DMF at 388 nm in aerobic 
conditions.  Monitored for 20 min with 532 nm light irradiation 
 
 
Figure 43: Rate constant (kobs (min
-1) for 1-nitropyrene in DMF at 388 nm in anaerobic 
conditions.  Monitored for 20 min with 532 nm light irradiation 
 





































Figure 44: Rate constant (kobs (min
-1) for 1-nitropyrene in DMF at 388 nm in aerobic 
conditions.  Monitored for 20 min with 556 nm light irradiation 
 
 
Figure 45: Rate constant (kobs (min
-1) for 1-nitropyrene in DMF at 388 nm in anaerobic 
conditions.  Monitored for 20 min with 556 nm light irradiation 
 










































Figure 46: Rate constant (kobs (min
-1) for 1-nitropyrene in ethanol at 388 nm in aerobic 
conditions.  Monitored for 20 min with 447 nm light irradiation 
 
 
Figure 47: Rate constant (kobs (min
-1) for 1-nitropyrene in ethanol at 388 nm in anaerobic 
conditions.  Monitored for 20 min with 447 nm light irradiation 
 
 







































Figure 48: Rate constant (kobs (min
-1) for 1-nitropyrene in ethanol at 388 nm in aerobic 
conditions.  Monitored for 20 min with 473 nm light irradiation 
 
 
Figure 49: Rate constant (kobs (min
-1) for 1-nitropyrene in ethanol at 388 nm in anaerobic 







































Figure 50: Rate constant (kobs (min
-1) for 1-nitropyrene in ethanol at 388 nm in aerobic 
conditions.  Monitored for 20 min with 532 nm light irradiation 
 
 
Figure 51: Rate constant (kobs (min
-1) for 1-nitropyrene in ethanol at 388 nm in anaerobic 
conditions.  Monitored for 20 min with 532 nm light irradiation 
 







































Figure 52: Rate constant (kobs (min
-1) for 1-nitropyrene in ethanol at 388 nm in aerobic 
conditions.  Monitored for 20 min with 556 nm light irradiation 
 
 
Figure 53: Rate constant (kobs (min
-1) for 1-nitropyrene in ethanol at 388 nm in anaerobic 
conditions.  Monitored for 20 min with 556 nm light irradiation 
 
 


































Figure 54: Rate constant (kobs (min
-1) for 1-nitropyrene with 1.0 x 10-2 M concentration 




Figure 55: Rate constant (kobs (min
-1) for 1-nitropyrene with 1.0 x 10-2 M concentration 
of H2O2 in ethanol at 388 nm in anaerobic conditions.  Monitored for 20 min with visible 
light irradiation 
 




































Figure 56: Rate constant (kobs (min
-1) for 1-nitropyrene with 1.0 x 10-3 M concentration 




Figure 57: Rate constant (kobs (min
-1) for 1-nitropyrene with 1.0 x 10-3 M concentration 
of H2O2 in ethanol at 388 nm in anaerobic conditions.  Monitored 20 min with visible 
light irradiation 
 

































Figure 58: Rate constant (kobs (min
-1) for 1-nitropyrene with 1.0 x 10-5 M concentration 




Figure 59: Rate constant (kobs (min
-1) for 1-nitropyrene with 1.0 x 10-5 M concentration 
of H2O2 in ethanol at 388 nm in anaerobic conditions.  Monitored 20 min with visible 
light irradiation 
 






































Figure 60: Emission spectrum of 1-nitropyrene with SOSG in DMF with irradiation at 
447 nm.  Monitored for 55 min in 5 min intervals.  0 min (light blue) 
 
 






































Figure 62: Emission spectrum of 1-hydroxypyrene with SOSG in DMF with irradiation 
at 447 nm.  Monitored for 30 min in 5 min intervals.  0 min (light blue) 
 
 





































Figure 64: Emission spectrum of 1-nitropyrene with APF in DMF irradiated with 447 
nm under aerobic conditions. 
 
 
Figure 65: Emission spectrum of 1-nitropyrene with APF in DMF irradiated with 447 



































Figure 66: Emission spectrum of 1-nitropyrene with APF & 1% DMSO in DMF 
irradiated at 447 nm.  Blue (0 min) 
 
 
Figure 67: Emission spectrum of 1-nitropyrene with APF and sodium azide in DMF 








































Figure 68: Emission spectrum of 1-hydroxypyrene with APF in DMF irradiated at 447 
nm under aerobic conditions.  Orange (0 min) 
 
 
Figure 69: Emission spectrum of 1HP with APF in DMF irradiated at 447 nm under 
































Figure 70: Emission spectrum of 1HP with APF & 1% DMSO in DMF irradiated at 447 
nm.  Gray (0 min) 
 
 
Figure 71: Emission spectrum of 1HP with APF & sodium azide in DMF irradiated at 








































Figure 72: Emission spectrum of 1-nitropyrene with HPF in DMF irradiated at 447 nm 
under aerobic conditions.  Orange (0 min) 
 
 
Figure 73: Emission spectrum of 1-nitropyrene with HPF in DMF irradiated at 447 nm 







































Figure 74: Emission spectrum of 1-nitropyrene with HPF & 1% DMSO in DMF 




Figure 75: Emission spectrum of 1-nitropyrene with HPF & sodium azide in DMF 





































Figure 76: Emission spectrum of 1HP with HPF in DMF irradiated at 447 nm under 
aerobic conditions.  Orange (0 min) 
 
 
Figure 77: Emission spectrum of 1HP with HPF in DMF irradiated at 447 nm under 

































Figure 78: Emission spectrum of 1HP with HPF & 1% DMSO in DMF irradiated at 447 
nm.  Gray (0 min) 
 
 
Figure 79: Emission spectrum of 1HP with HPF & sodium azide in DMF irradiated at 

































After 48 Hours 
  
Control 1: 500 uL H2O  
under dark 
 




C: 495 uL H2O; 5 uL DMF  
under dark 
 







E: 495 uL H2O; 5 uL 0.01 M 1-NP  
under dark 




G: 495 uL H2O; 5 uL 0.01 M 1-HP  
under dark 
 




Figure 80: Bacteria study of 1-nitropyrene & 1-hydroxypyrene with E. coli under dark 
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